Aims: Hypoglycaemia is associated with increased cardiovascular risk among individuals with diabetes mellitus. It has been hypothesized that hypoglycaemia may trigger autonomic changes leading to increased cardiac arrhythmia risk. We conducted a systematic review and metaanalysis to explore this association. Conclusion: Our findings suggest that hypoglycaemia results in ECG alterations that are associated with increased risk of cardiac arrhythmia, which is associated with increased cardiovascular events and mortality. More clinical studies are needed to determine the cardiac risks of hypoglycaemia in individuals with diabetes, especially in Type 2 diabetes.
has been conducted to explore the underlying pathophysiological mechanisms. While convincing evidence demonstrates the adverse effects of hyperglycaemia on CVD development, meta-analyses of large clinical trials suggest that hypoglycaemia may also contribute to poor CVD outcomes. 4, 5 What remains unknown is whether hypoglycaemia serves as a marker of vulnerability to cardiovascular events or whether it triggers a direct causal effect.
In 1991, Tattersall and Gill 6 described a series of cases of sudden, unexplained, nocturnal deaths among young indviduals with type 1 diabetes (T1DM). Asymptomatic patients who had gone to sleep at night were later found dead in undisturbed beds. Circumstantial evidence suggests that nocturnal hypoglycaemia, subsequently described as "dead in bed syndrome" may be to blame. While the results of a recent meta-analysis report that intensive glucose lowering is associated with significant reductions in the risk of non-fatal myocardial infarction (MI), 7 the results of 3 large scale clinical trials, considered individually, have shown no benefit, with 1 study demonstrating a detrimental effect on overall cardiovascular outcomes. [8] [9] [10] Although subjectively measured, intensive management was associated with a significant increase in the frequency and severity of hypoglycaemia.
While hypoglycaemia is common, particularly among individuals with T1DM, sudden deaths are rare, 11, 12 which suggests the interplay of several contributing factors, resulting in the development of adverse cardiac events under certain conditions. As many episodes of hypoglycaemia are unrecognised, the exact mechanism underpinning this relationship has not been clearly established. It has been hypothesized that hypoglycaemia may trigger acute electrocardiographic (ECG) changes which increase an individual's vulnerability to arrhythmic events, leading to adverse outcomes such as sudden cardiac death. 13, 14 If the underlying mechanisms are identified, clinicians may be able to identify the individuals most at risk and therefore modify and personalize management and improve patient outcomes.
We conducted a systematic review and meta-analysis of clinical human studies that explored both experimentally induced and spontaneous clinical hypoglycaemia, identified through continuous glucose monitoring (CGM), to evaluate the acute effects of hypoglycaemia that contributie to the risk of cardiac arrhythmia (CA) in adults with T1DM and T2DM. We particularly sought to compare differences in the duration of the QT corrected for heart rate (QTc)-interval between euglycaemic and hypoglycaemic periods; however, changes in heart rate variability (HRV) and incidence of arrhythmia were also compared.
| MATERIALS AND METHODS
This systematic review and meta-analysis has been registered on Controlled Trials from inception to October 9, 2017. We searched using the terms "diabetes mellitus" (T1DM and T2DM), "hypoglycaemia" and "cardiac arrhythmias" and a combination of medical subject headings, keywords and synonyms, with both English and American
spellings. An example search strategy, modified for Ovid Medline, can be found online in (Appendix S1). We hand searched the reference lists and forward citations of included articles and contacted authors of conference abstracts.
Two investigators (C. F. and S. S.) independently screened titles and abstracts and examined full texts of potentially eligible articles, using pre-specified inclusion criteria. Discrepancies were resolved through discussion. We included comparative observational studies (changes in hypoglycaemia, identified through CGM and ECG by ambulatory Holter monitoring) and experimental studies (induced hypoglycaemia) in which glycaemic and cardiac monitoring were performed simultaneously. These studies were conducted among adult patients (≥18 years) with T1DM or T2DM, and they compared compared acute cardiac changes in QTc, HRV and any CAs between episodes of hypoglycaemia and euglycaemia. We included articles published in any language. We excluded case studies and studies that retrospectively reviewed hospital records because of their lack of generalizability and/or poor data quality. Where possible, data relating to T1DM and T2DM were extracted separately. We contacted study authors if available data were insufficient within the publication.
| Data collection
We assessed quality by adapting the criteria suggested by the National Institutes of Health Quality Assessment Tool for Observational Cohort and Cross-Sectional studies 17 and the Cochrane Collaboration Risk of Bias Tool. 18 Quality was evaluated based on study design, participant selection, exposure assessment, outcome assessment and adjustment for potential cofounders. Publication bias and selective reporting bias were assessed using the symmetry of the funnel plot.
| Statistical analysis
For QTc interval duration, we calculated standardized means using formulae described previously. 19 Pooled standardized mean differences (SMD) were estimated using random-effects meta-analysis to account for heterogeneity in study design and population characteristics. We calculated heterogeneity using the I 2 statistic and publication bias was assessed using the Egger test. I 2 < 25%, 25%-75% and > 75% was considered low, moderate and high heterogeneity, respectively.
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Among studies, QTc was calculated using a variety of different formulae, and in some studies 2 or more were calculated and compared. Bazett's formula (QTb) 21 was used most widely and, where available, QTb data were used within the meta-analysis. Where QTb data were unavailable, subject specific (n = 2) 22 or unknown formulae (n = 1) 23 and HbA1c (continuous, mean %).
We performed sensitivity analyses by first excluding 2 studies that identified their data as non-normally distributed and which were included in the meta-analysis by estimating the mean from the median and the standard deviation from the range. 19 Second, although QTb is the most commonly used formula for QTc, data have suggested that it is not optimal. 25, 26 A sensitivity analysis favouring QT corrected by
Frederica's formula, the second most commonly reported method, was undertaken. The following heart rate correction formulae were combined in this analysis: Frederica (n = 5), Bazett (n = 6), subject specific (n = 3) and unknown (n = 1). Finally, we systematically excluded 1 study at a time from the analysis and assessed any change in pooled effect size.
All analyses were performed using Stata V14.1 (StataCorp) with the METAN, METAREG and METANINF commands. Results were reported with 95% confidence intervals (CI); P < Á05 was considered statistically significant. We used descriptive data synthesis to summarize findings relating to HRV and CA to account for the heterogeneity of study designs and outcome measures reported.
| RESULTS
Our initial search yielded 4625 citations, of which 67 full texts were assessed for eligibility ( Figure 1 ). After examination, 24 publications from 21 studies were considered eligible. [22] [23] [24] Duplicate publications of 3 studies were identified. [29] [30] [31] [32] 34, 36 As the articles reported different study outcomes, both were included in the review; however, they were acknowledged as a single study that will henceforth be referenced by the original publication. During data extraction a further article had to be excluded; 47 (n = 1). 38 The remaining 12 studies involved experimentally induced hypoglycaemia in participants with T1DM (n = 6), 28, 31, 33, 36, 40, 42 with T2DM (n = 5) 24, 27, 39, 41, 46 or with both (n = 1). 43 The (observational, n = 7; experimental, n = 10), 7 studies (observational, n = 4; experimental, n = 3) and 7 studies (observational, n = 6; experimental, n = 1), respectively. Characteristics of the included studies appear in Table 1. A total of 17 studies reported outcome data for QTc. As two of these studies reported mean change between the conditions, as opposed to absolute mean values, random effects meta-analysis was possible for only 15 studies. [22] [23] [24] 28, 29, 31, 33, 35, 36, [38] [39] [40] [43] [44] [45] The two studies excluded from the meta-analysis 27,42 reported a significant increase in QTc length during hypoglycaemia (P < .05).
We did meta-analysis of 15 studies for changes in QTc duration;
five reported a significant increase (P < .05); nine reported a nonsignificant increase (P > .05); and one reported that QTc duration significantly decreased with hypoglycaemia (P < .05). Pooled SMD (95% Cl) of the 15 studies showed that hypoglycaemia was associated with significant QTc prolongation as compared to euglycaemia 0.64 (0.27-1.01); P = .001.
We report significant, moderate heterogeneity among studies (I 2 = 63.9; P < .001). To examine possible sources of heterogeneity, we carried out sub-group analyses according to study design and dia- The only observation of note was that removal of the study by Koivikko et al. 35 led to a reduction in the width of the CI. ger any significant effects on HRV; however, during the day, hypoglycaemia triggered significant reductions in TP, 22 Log HF 22 and Log LF. 22, 45 In total, 7 studies assessed the occurrence of CA. 22, 23, 31, 35, 41, 44, 45 Of these, 1 reported no incidence 3 and 2 reported the occurrence of ventricular premature beats (VPB) across both glycaemic conditions. 31, 41 In 1 study, 41 an episode of bradycardia was also reported in 1 patient; however, this occurred during a period of euglycaemia (BG 4Á4 mmoL/L) although the patient reported experiencing symptoms of hypoglycaemia. In 1 study the occurrence of VPB, sinus bradycardia or atrial premature beats (APB) was reported in 7 out of 13 hypoglycaemic episodes, with no alterations observed during euglycaemia. 23 In 2 studies the incident rate ratios (IRR) of the following arrhythmias was reported: bradycardia, APB, VPB, complex VPB (bigeminy, trigeminy, couplets, Salvos and ventricular tachycardia) and total VPB during nocturnal and daytime periods. 22, 45 Under nocturnal hypoglycaemic conditions, significant increases in IRR of bradycardia were reported in both studies. Hypoglycaemia triggered an 8-fold increase in the study involving T2DM Most studies received an average quality rating, typically scoring poorly because of lack of specified inclusion/exclusion criteria for participant eligibility, sample size justification and blinding of outcome analyst. A breakdown of study quality is presented in Appendix S3.
| DISCUSSION
To our knowledge, this is the first systematic review and metaanalysis to explore the acute effects of hypoglycaemia on CA risk.
Studies of experimental and observational design were considered so that trial data and real-world evidence could be compared.
Our findings suggest that hypoglycaemia triggers a significant increase in QTc and a reduction in HRV, both of which have been identified as markers of risk of mortality and sudden cardiac death in individuals with diabetes. 48, 49 Few studies looked at incidence of arrhythmia directly; however, our findings suggest that occurrence increased with hypoglycaemia, particularly under nocturnal conditions, thus supporting the notion that hypoglycaemia may explain the dead in bed syndrome in susceptible individuals.
Previous large-scale prospective studies have shown disconcerting cardiovascular outcomes with intensive management of individuals with T2DM (target glycated haemoglobin level < 6.0%) which may be attributable to hypoglycaemia. [8] [9] [10] While findings from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial showed that rates of non-fatal MI were lower in the group receiving intensive management, mortality rates were increased in this group with increased mortality attributed to fatal MI, arrhythmias and congestive heart failure, leading to early trial termination. 8 Despite these findings, and identification of a possible association between hypoglycaemia and CVD, evidence of a direct causal link is lacking. 5, 8, 50 This review builds upon previous research by identifying potential mechanisms by which hypoglycaemia may be associated with cardiovascular morbidity and mortality.
While our meta-analysis revealed that hypoglycaemia was associated with significant QTc prolongation, the strength of the association varied when results were stratified by study design and diabetes type.
Experimental studies triggered a more profound increase in QTc prolongation. This may be explained by differences in the glycaemic threshold used to define hypoglycaemia. Typically, observational studies classified hypoglycaemia as interstitial glucose <3.5 mmol/L, whereas experimental studies used <3.0 mmol/L, a figure in line with current clinical definitions. 51 Additionally, the influence of confounders among observational studies that lack controlled conditions should also be considered. In contrast, while the highly controlled and widely used hyperinsulinaemic-euglycaemic clamp technique provides an ideal model for demonstrating mechanisms by which hypoglycaemia may increase the risk of arrhythmia, it does not deliver a true reflection of insulin and glucose dynamics and the sympathoadrenal responses during spontaneous clinical hypoglycaemia. 28 In relation to diabetes type, QTc prolongation occurred in individuals with T1DM and T2DM; however, among those with T2DM the change between euglycaemia did not reach statistical significance. As far fewer studies have been conducted in T2DM, the ability to ascertain firm conclusions within this population is limited.
As previously mentioned, the QT correction formula can also influence results with Bazett's, the most commonly adopted correction formula, over correcting the QT interval duration at faster heart rates and under correcting at slower heart rates. 25, 26 In addition, while the ECG is an easily accessible and established tool to assess cardiac rhythm and electrophysiological properties, it is acknowledged that accurate QT interval measurements can be challenging. 52 Our review was based on strict inclusion and exclusion criteria, and two authors independently reviewed and identified potentially eligible articles. Limitations of this review include the fact that the number of studies included in the meta-analysis was modest and their sample sizes were small. There was moderate heterogeneity across the studies, ranging from design and participant characteristics to intervention and reported outcomes. These could be the result of differing primary study objectives, with some studies focusing on more specific ECG alterations. At review level, the lack of comparable outcomes among studies meant that further meta-analyses were not possible, which led to less reliable descriptive data synthesis of the incidence of HRV and arrhythmia concerning some outcomes rather than a more robust meta-analysis. To minimize bias, we reported and explained the results of each study in a structured and logical manner.
Despite the fact that the results of the funnel plot and Egger's tests suggest no obvious publication bias, the possibility of bias remains. During study selection, a number of potentially eligible conference abstracts were identified; however, full texts could not be obtained. Elements of reporting bias were also acknowledged, as contact with numerous authors was required to obtain all relevant information. In some cases, the failure to make contact prevented inclusion of the study or certain outcome data in the analysis. During title and abstract screening, three titles of articles written in Spanish (n = 2) 53, 54 or German (n = 1) 55 and the abstract of a Russian article 56 were identified as potentially eligible. As further detail could not be obtained in English we could not identify whether these studies met our inclusion criteria.
In summary, this review confirms that hypoglycaemia triggers acute ECG alterations in individuals with diabetes, which may increase an individual's vulnerability to arrhythmic events, leading to subsequent cardiovascular morbidity and mortality. These findings may explain detrimental cardiac outcomes in intensively controlled patients who are at greater risk of hypoglycaemia. Considerably less research to explore the association between hypoglycaemia and CA risk has been conducted in T2DM.
T2DM is strongly associated with ischaemic heart disease, 57 particularly among individuals of advancing age and disease duration, and previous research has reported increased frequency of ischaemia and chest pain during hypoglycaemia. This may be representative of cardio-acceleration, possibly suggesting that these individuals may be particularly susceptible.
As T2DM is typically associated with an older population and its prevalence and comorbidities are increasing, 1,2 more research within this cohort is warranted. Studies of longer duration and greater participant numbers would help to support the capture of hypoglycaemia events and its subsequent impact on the risk of arrhythmia. Additional studies that explore the impact of confounders, for example, exercise, ethnicity, rate of descent of blood glucose leading to hypoglycaemia, and the impact of medications known to affect heart rate and rhythm such as beta-blockers and the extent to which they attenuate risk would further benefit our understanding. Of the 20 studies included in this review, 11 specified that individuals receiving medication known to affect cardiac rhythm were excluded, and a further 8 made no reference to the topic. The initial study by Chow and colleagues, 22 revealed that 2 out of 25 participants were tusng beta blockers; however, sensitivity analyses that excluded these individuals were not associated with changes in risk of arrhythmia. Further studies with larger comparative sample sizes are required to accurately explore the impact of such medications on risk.
Finally, QT interval per se is not an absolute marker of the risk of arrhythmia, although there are inherited and acquired long QT syndromes that predispose to lethal arrhythmias. The QT interval is a surrogate measurement of the averaged ventricular action potential duration (APD). More recently, it is recognized that it is the dynamic behaviour of the APD (and QT interval) to changes in heart rate, termed APD restitution, that is an important marker of the risk of arrhythmia. 58 Electrical restitution can be measured on the ECG as prognostic risk markers in patients at risk of sudden cardiac death 59 and has been shown to be an important mechanism underlying the autonomic modulation of ventricular fibrillation initiation. 60 These properties are potentially important parameters in the investigation of the association between the effects of hypoglycaemia on QT interval and arrhythmia risk. 60 
